Effects of benzo[a]pyrene on tissue activities of metabolizing enzymes and antioxidant system in normal and protein-malnourished rats

Journal of Biochemical and Molecular Toxicology

Volumn 17, Issue 2, 2003, Pages 86-91

  Badary, Osama A ^a   AbdEl Gawad, Hanan M ^b   Taha, Ragia A ^a   Ali, Azza A ^a   Hamada, Farid M A ^a  

^a Al Azhar University   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Antioxidants; Benzo a pyrene; Metabolising enzymes; Protein malnutrition; Rat

Indexed keywords

ANTIOXIDANT; BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME P450 1A1; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LIPID PEROXIDE; LIVER ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER; LUNG; MALE; NONHUMAN; PROTEIN MALNUTRITION; RAT; STATISTICAL ANALYSIS; STOMACH; TISSUE LEVEL;

ANIMALS; ANTIOXIDANTS; BENZO(A)PYRENE; CYTOCHROME P-450 CYP1A1; CYTOSOL; DIET; ENVIRONMENTAL POLLUTANTS; ENZYMES; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LIPID PEROXIDES; LIVER; LUNG; MALE; NAD(P)H DEHYDROGENASE (QUINONE); PROTEIN-ENERGY MALNUTRITION; RATS; RATS, WISTAR; STOMACH; SUPEROXIDE DISMUTASE;

EID: 0037648978     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.10064     Document Type: Article

References (39)

1. Collins JF, Brown JB, Dawson SV, Marten MA. Risk assessment of benzo(a)pyrene. Regul Toxicol Pharmacol 1991;13:170-184.
2. Khanduja KL, Koul IB, Sehgal S. Influence of combined deficiency of fat and vitamin A on benzo(a)pyrene-induced lung carcinogenesis in rats. Indian J Exp Biol 1994;32(2):124-127.
3. Chen W, Zhou Y, Nichols J, Chung KT, Hart RW, Chou MW. Effect of dietary restriction on benzo[a]pyrene metabolic activation and pulmonary BaP-DNA adduct formation in mouse. Drug Chem Toxicol 1996;19(1/2):21-39.
4. Porter TD, Coon MJ. Cytochrome P450 multiplicity of isoforms, substrates, catalytic and regulatory mechanisms. J Biol Chem 1991;266:13469-13472.
5. Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 1988;40:243-288.
6. Guengerich FP. Reactions and significance of cytochrome P450 enzymes. J Biol Chem 1991;260:10019-10022.
7. Gonzalez FJ, Gelboin HV. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Met Rev 1994;26(1/2):165-183.
8. Benson AM, Hunkeler MJ, Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 1980;77(9):5216-5220.
9. Fisher MB, Paine MF, Strelovitz TJ, Wrighton SA. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 2001;33(3/4):273-297.
10. Raza H, Ahmed I, Lakhani MS, Sharma AK, Pallot D, Montague W. Effect of bitter melon (Momordica charantia) fruit juice on the hepatic cytochrome P450-dependent monooxygenases and glutathione S-transferases in streptozotocin-induced diabetic rats. Biochem Pharmacol 1996;52:1639-1642.
11. Konstandi M, Johnson E, Lang MA, Camus-Radon AM, Marselos M. Stress modulates the enzymatic inducibility by benzo[a]pyrene in the rat liver. Pharmacol Res 2000;42(3):205-211.
12. Pangrekar J, Krishnaswamy K, Jagdeesan. Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding. Food Chem Toxicol 1993;31(10):745-750.
13. Anthony LE, Edozine JC. Experimental protein and energy deficiencies in rat. J Nutr 1975;105:631-648.
14. Matsui M, Watanabe HK. Developmental alteration of hepatic UDP-glucuronosyltransferase and sulphotransferase towards aldosterone and 4-nitrophenol in Wistar rats. Biochem J 1982;204:441-447.
15. Lowry OH, Roseborough NJ, Farr AL, Randall RL. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193(1):265-275.
16. Burke MD, Mayer RT. Ethoxyresorufin: Direct fluorimetric assay of a microsomal O-dealkylation, which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos 1974;2(6):583-588.
17. Bock KW, Burchell B, Ditton GJ, Hanninen O, Mulder GJ, Owens IS, Siest G, Tephly TR. UDP-glucuronosyltransferase activities: Guidelines for consistent interim terminology and assay condition. Biochem Pharmacol 1983;32(6):953-955.
18. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferase, the first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
19. Beutler E, Durom O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-888.
20. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
21. Recknagel RO, Glende Jr EA. Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol 1984;105:331-337.
22. Marklund SL, Marklund G. Involvement of the superoxide anion radical in the autooxidation of pyrogallol and convenient assay for superoxide dismutase. Eur J Biopchem 1974;47:469-474.
23. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-1210.
24. Kato R. Drug metabolism under pathological and abnormal physiological states in animals and man. Xenobiotica 1977;7(1/2):25-92.
25. Narang AP. Effect of protein-calorie malnutrition on drug metabolising enzymes in rat liver. Indian J Physiol Pharmacol 1987;31(3):170-177.
26. Albrecht R, Pelissier MA, Miladi N, Atteba S, Desfontaines C, Narbonne JF. Protein restriction and metabolism of xenobiotics. Ann Nutr Metab 1986;30(2):73-80.
27. Marten NW, Sladek FM, Straus DS. Effect of dietary protein restriction on liver transcription factors. Biochem J 1996;317(Part 2):361-370.
28. Walter-Sack I, Klotz U. Influence of diet and nutritional status on drug metabolism. Clin Pharmacokinet 1996;31(1):47-64.
29. Rao NJ, Jagadeesan V. Effect of long term iron deficiency on the activities of hepatic and extrahepatic drug metabolising enzymes in Fischer rats. Comp Biochem Physiol B Biochem Mol Biol 1995;110(1):167-173.
30. Jagadeesan V. Study of activating and conjugating enzymes of drug metabolism in zinc deficiency. Indian J Exp Biol 1989;27(9):799-801.
31. Monks TJ, Anders MW, Dekant W, JL, Lau SS, Bladeren PJ. Glutathione conjugate mediated toxicities. Toxicol Appl Pharmacol 1990;106:1-19.
32. Kim KB, Lee BM. Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and catalase) in rats treated with benzo(a)pyrene. Cancer Lett 1997;113(1/2):205-212.
33. Yang CS, Smith TJ, Hong JY. Cytochrome P450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: Opportunities and limitations. Cancer Res 1994;54:1982-1986.
34. Thapliyal R, Maru GB. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Food Chem Toxicol 2001;39:541-547.
35. Nebert DW. Drug metabolising enzymes in ligand-modulated transcription. Biochem Pharmacol 1994;47(1): 25-37.
36. Zheng Z, Fang JL, Lazarus P. Glucuronidation: An important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab Dispos 2002;30(4):397-403.
37. Zheng Z, Park JY, Guillemette C, Schantz SP, Lazarus P. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 2001;93:39-46.
38. Bock KW. Roles of UDP-glucuronosyltransferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 1991;26:129-150.
39. Lamb JG, Franklin MR. Early events in the induction of rat hepatic UDP-glucuronosyltransferases, glutathione S-transferase, and microsomal epoxide hydrolase by 1,7-phenanthroline: Comparison with oltipraz, tert-butyl-4-hydroxyanisole and tert-butylhydroquinone. Drug Metab Dispos 2000;28(9):1018-1023.